Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NBP606 Booster Vaccination in Healthy Toddlers
NCT02927444Phase 3Completed
- Sponsor
- SK Chemicals
- Start
- Nov 2015
- Primary completion
- Oct 2017
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of NBP606 in pneumococcal infection (2 arms), sponsored by SK Chemicals. Primary endpoint: Proportion of subjects with the targeted antibody concentration. Started Nov 2015; status: completed.
02
Drugs
NBP606
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT02927444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02927444.